A detailed history of Northwestern Mutual Investment Management Company, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Investment Management Company, LLC holds 29,464 shares of HALO stock, worth $1.56 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
29,464
Previous 29,389 0.26%
Holding current value
$1.56 Million
Previous $1.09 Million 10.31%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$33.68 - $41.95 $2,526 - $3,146
75 Added 0.26%
29,464 $1.2 Million
Q4 2023

Feb 13, 2024

BUY
$33.32 - $42.1 $4,364 - $5,515
131 Added 0.45%
29,389 $1.09 Million
Q3 2023

Nov 14, 2023

SELL
$36.46 - $44.03 $218 - $264
-6 Reduced 0.02%
29,258 $1.12 Million
Q2 2023

Aug 14, 2023

SELL
$30.28 - $38.74 $22,225 - $28,435
-734 Reduced 2.45%
29,264 $1.06 Million
Q1 2023

May 15, 2023

BUY
$32.86 - $55.7 $574,557 - $973,914
17,485 Added 139.73%
29,998 $1.15 Million
Q4 2022

Feb 21, 2023

SELL
$40.06 - $59.44 $295,883 - $439,023
-7,386 Reduced 37.12%
12,513 $711,000
Q3 2022

Nov 14, 2022

SELL
$38.53 - $51.78 $122,987 - $165,281
-3,192 Reduced 13.82%
19,899 $787,000
Q2 2022

Aug 04, 2022

SELL
$37.35 - $48.3 $10,906 - $14,103
-292 Reduced 1.25%
23,091 $1.02 Million
Q1 2022

May 09, 2022

BUY
$31.97 - $41.06 $1,406 - $1,806
44 Added 0.19%
23,383 $933,000
Q4 2021

Feb 03, 2022

SELL
$31.82 - $40.75 $5,504 - $7,049
-173 Reduced 0.74%
23,339 $938,000
Q3 2021

Nov 15, 2021

BUY
$38.47 - $46.42 $47,010 - $56,725
1,222 Added 5.48%
23,512 $956,000
Q2 2021

Aug 13, 2021

BUY
$38.84 - $51.31 $41,908 - $55,363
1,079 Added 5.09%
22,290 $1.01 Million
Q1 2021

May 14, 2021

SELL
$39.51 - $51.45 $888,184 - $1.16 Million
-22,480 Reduced 51.45%
21,211 $884,000
Q4 2020

Feb 12, 2021

BUY
$25.81 - $43.62 $1.13 Million - $1.91 Million
43,691 New
43,691 $1.87 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.37B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Northwestern Mutual Investment Management Company, LLC Portfolio

Follow Northwestern Mutual Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Investment Management Company, LLC with notifications on news.